State of Alaska, Department of Revenue - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 117 filers reported holding ANI PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.90 and the average weighting 0.1%.

Quarter-by-quarter ownership
State of Alaska, Department of Revenue ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$579
+17.4%
9,975
+8.9%
0.01%
+16.7%
Q2 2023$493
+48.5%
9,162
+9.5%
0.01%
+50.0%
Q1 2023$332
-2.9%
8,366
-1.7%
0.00%0.0%
Q4 2022$342
-99.9%
8,507
+1.8%
0.00%0.0%
Q3 2022$268,000
-1.1%
8,359
-8.8%
0.00%
+33.3%
Q2 2022$271,000
+9.3%
9,166
+3.6%
0.00%0.0%
Q1 2022$248,000
-29.7%
8,846
+15.4%
0.00%0.0%
Q4 2021$353,000
+49.6%
7,666
+6.6%
0.00%
+50.0%
Q3 2021$236,000
-1.7%
7,191
+4.7%
0.00%0.0%
Q2 2021$240,000
+2.1%
6,869
+5.4%
0.00%
-33.3%
Q1 2021$235,000
+8.3%
6,519
-13.0%
0.00%
+50.0%
Q4 2020$217,000
-13.9%
7,489
-16.3%
0.00%
-33.3%
Q3 2020$252,000
-10.6%
8,952
+2.6%
0.00%
-25.0%
Q2 2020$282,000
-19.7%
8,722
+1.2%
0.00%
-33.3%
Q1 2020$351,000
-18.9%
8,622
+22.8%
0.01%0.0%
Q4 2019$433,000
-16.7%
7,022
-1.6%
0.01%
-14.3%
Q3 2019$520,000
+121.3%
7,138
+149.5%
0.01%
+75.0%
Q2 2019$235,000
+19.3%
2,861
+2.4%
0.00%
+33.3%
Q1 2019$197,000
+58.9%
2,794
+1.3%
0.00%
+50.0%
Q4 2018$124,000
-25.7%
2,759
-7.1%
0.00%
-33.3%
Q3 2018$167,000
-15.7%
2,9690.0%0.00%
-25.0%
Q2 2018$198,000
+18.6%
2,969
+3.1%
0.00%
+33.3%
Q1 2018$167,000
+46.5%
2,879
+61.8%
0.00%0.0%
Q4 2017$114,000
+22.6%
1,7790.0%0.00%
-40.0%
Q3 2017$93,000
+25.7%
1,779
+12.0%
0.01%0.0%
Q2 2017$74,000
+72.1%
1,589
+80.6%
0.01%
+66.7%
Q1 2017$43,000
-17.3%
880
+2.3%
0.00%
-40.0%
Q4 2016$52,0008600.01%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
AIGH Capital Management LLC 272,801$15,838,8267.50%
Global Alpha Capital Management Ltd. 525,528$30,512,1563.06%
Rubric Capital Management LP 847,011$49,177,4591.84%
Ranger Investment Management 426,848$24,782,7951.64%
Parkman Healthcare Partners LLC 111,802$6,491,2241.19%
MARATHON CAPITAL MANAGEMENT 71,670$4,161,1601.05%
Mesirow Financial Investment Management, Inc. 3,862$224,2280.98%
Deep Track Capital, LP 400,000$23,224,0000.90%
1492 Capital Management LLC 18,178$1,055,4150.68%
Phocas Financial Corp. 75,213$4,367,0000.64%
View complete list of ANI PHARMACEUTICALS INC shareholders